Patents, Data Exclusivity, and the Development of New Drugs
176
Patents, Data Exclusivity, and the Development of New Drugs
The Disciplinary Effect of Post-Grant Review
Causal Evidence From European Patent Opposition
155
Measuring the Spillovers of Venture Capital
46
Competition and Incentives
31